Growth hormone responses to apomorphine HCl in schizophrenic patients on drug holidays and at relapse.
In nine schizophrenic patients on drug holiday, growth hormone (GH) response to apomorphine HCl 0.75 mg (APO) was compared with normal control data. Patients were tested at two month intervals for up to 14 months. Seven patients relapsed, and of these, five had exaggerated GH responses to APO at that time. Of these five, three had exaggerated GH responses to APO prior to clinical deterioration. Further work is required to determine whether this test can be a useful predictor of relapse.
D000328:Adult; D014150:Antipsychotic Agents / Q000627:therapeutic use; D001058:Apomorphine; D004305:Dose-Response Relationship, Drug; D005260:Female; D013006:Growth Hormone / Q000097:blood / Q000378:metabolism*; D006801:Humans; D008137:Longitudinal Studies; D008297:Male; D012008:Recurrence; D012559:Schizophrenia / Q000097:blood / Q000175:diagnosis* / Q000188:drug therapy / Q000503:physiopathology
D014150:Antipsychotic Agents; D013006:Growth Hormone; D001058:Apomorphine